Press release
Awards success for Dundee collaboration
Published on 21 March 2024
Ground-breaking drug discovery work at the University of Dundee has been honoured at a national awards ceremony.
The University’s Centre for Targeted Protein Degradation (CeTPD) was honoured for its work with industry partner, Boehringer Ingelheim. The duo won the Further, Faster, Together (Industry-Academia Collaboration) prize at a ceremony hosted by Cancer Research Horizons, the innovation arm of Cancer Research UK.
The University is working with the pharmaceutical company on the development of proteolysis targeting chimaeras (PROTACS), novel drugs that target previously considered ‘undruggable’ drivers of cancer progression.
The Cancer Research Horizons Innovation & Entrepreneurship Awards celebrate entrepreneurial initiative, leadership, and innovation in advancing cancer research, developing novel therapies, diagnostics and medical devices.